Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-09-15 00:00:00 ET · period of report 2022-09-13 · accession 0001209191-22-050038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-15 | 2022-09-13 | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $28.00 | -349 | 35.9K | -1.0% | -$9,772 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-13 | S | D | 349 | $28.00 | 35,933 | D | — | — | (F2) Includes 549 shares of the Issuer's common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program. |